[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
Authors:
- W BirkmayerWBW Birkmayer
- W LinauerWLW Linauer
- M MentastiMMM Mentasti
- P RiedererPRP Riederer
- 1 June 1974
- journal article
- clinical trial
- Vol. 124 (22) , 340-4